UNSPSC 51182013: Stanozolol

This classification denotes a therapeutic androgen and anabolic steroid with the molecular formula C21H32N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4R1VB9P8V3, chemically known as 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol but generally known as stanozolol, which bears US NIH Compound Identifier 25249. European Medicines Agency schedules Stanozolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10641MIG.

UNSPSC 51182013 Stanozolol, a Commodity code, addresses the procurement of this anabolic steroid pharmaceutical product by state and local governments. The source provides no record of recent state or local contract opportunities under this code.

The absence of recent solicitation activity under this Commodity code suggests minimal or no current demand from state and local procurement offices for stanozolol. This outcome is consistent with the controlled and restricted status of anabolic steroids in most U.S. jurisdictions outside specialized medical and veterinary contexts, where procurement would typically route through different channels or regulatory frameworks rather than open competitive bidding.